aTYR PHARMA (ATYR) Short-term Investments (2014 - 2026)
aTYR PHARMA's Short-term Investments was $41.26 million in Q2 2026, down 34.6% from $63.13 million a year earlier and down 27.0% from the prior quarter.
Powered by 
Analysis
aTYR PHARMA (ATYR) Short-term Investments (2014 - 2026) Analysis & Trends
At the end of FY2025, Short-term Investments at aTYR PHARMA came in at $67.94 million, up 11.3% from FY2024.
- Short-term Investments shows a five-year compound annual growth rate of 35.8% (FY2020 to FY2025).
- In earlier years, Short-term Investments was $61.07 million in FY2024 (-19.2%), $75.62 million in FY2023 (+34.6%), $56.17 million in FY2022 (-46.8%) and $105.58 million in FY2021 (+616.4%).
- The Q2 2026 figure marks the lowest quarterly Short-term Investments since Q1 2021.
- Compared with a year earlier, Short-term Investments was higher in two of the last eight quarters, with an average decline of 8.8%.
- The best year-over-year quarter for Short-term Investments over five years was Q4 2021 (growth of 616.4%); the worst was Q4 2022 (a decline of 46.8%).
- Per Business Quant data, ATYR's Short-term Investments in the three quarters before Q2 2026 was $56.51 million (Q1 2026), $67.94 million (Q4 2025) and $84.05 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.13 Bn | 1,100.72 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 634.87 Bn | 554.73 Bn | 17.30 Bn |
| 3 | AbbVie | 506.59 Bn | 479.70 Bn | 12.70 Bn |
| 4 | Merck | 357.59 Bn | 311.97 Bn | 12.21 Bn |
| 5 | Novartis Ag | 291.51 Bn | 255.50 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.00 Bn | 238.69 Bn | 12.86 Bn |
| 7 | Amgen | 238.17 Bn | 193.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.18 Bn | 169.37 Bn | 6.22 Bn |
| 9 | Pfizer | 171.20 Bn | 117.84 Bn | 10.94 Bn |
| 10 | aTYR PHARMA | 16.10 Mn | -276.72 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.26 Mn |
| Mar 31, 2026 | 56.51 Mn |
| Dec 31, 2025 | 67.94 Mn |
| Sep 30, 2025 | 84.05 Mn |
| Jun 30, 2025 | 63.13 Mn |
| Mar 31, 2025 | 65.99 Mn |
| Dec 31, 2024 | 61.07 Mn |
| Sep 30, 2024 | 54.53 Mn |
| Jun 30, 2024 | 71.68 Mn |
| Mar 31, 2024 | 77.69 Mn |
| Dec 31, 2023 | 75.62 Mn |
| Sep 30, 2023 | 92.34 Mn |
| Jun 30, 2023 | 96.27 Mn |
| Mar 31, 2023 | 93.70 Mn |
| Dec 31, 2022 | 56.17 Mn |
| Sep 30, 2022 | 59.02 Mn |
| Jun 30, 2022 | 80.07 Mn |
| Mar 31, 2022 | 90.34 Mn |
| Dec 31, 2021 | 105.58 Mn |
| Sep 30, 2021 | 56.61 Mn |
API Access
aTYR PHARMA Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=ATYR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "ATYR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=ATYR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();